What test is done after a positive Rapid Plasma Reagin (RPR) test for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Confirmatory Testing After Positive RPR for Syphilis

After a positive Rapid Plasma Reagin (RPR) test for syphilis, a treponemal-specific test such as TP-PA (Treponema pallidum particle agglutination) or FTA-ABS (fluorescent treponemal antibody absorption) should be performed as confirmatory testing. 1

Understanding Syphilis Testing Algorithms

There are two main testing approaches for syphilis:

  1. Traditional Algorithm:

    • Initial screening with nontreponemal test (RPR or VDRL)
    • Confirmation of positive results with treponemal-specific test
  2. Reverse Sequence Algorithm:

    • Initial screening with treponemal test
    • Confirmation of positive results with nontreponemal test

When an RPR test is positive, confirmatory testing is essential because nontreponemal tests can yield false-positive results in various conditions.

Recommended Confirmatory Tests

The CDC recommends the following treponemal tests for confirmation after a positive RPR 1:

  • TP-PA (Treponema pallidum particle agglutination) - preferred option due to:

    • High sensitivity (95-100%)
    • Excellent specificity (100%)
    • Superior sensitivity compared to FTA-ABS, especially in primary syphilis
  • Other acceptable options:

    • FTA-ABS (fluorescent treponemal antibody absorption)
    • EIA (enzyme immunoassay)
    • CIA (chemiluminescence immunoassay)

Performance of Confirmatory Tests

Treponemal tests have different performance characteristics 1, 2:

Test Sensitivity Specificity Notes
TP-PA 95-100% 100% Preferred for adjudicating discordant results
FTA-ABS 78.2-95% 95-100% Less sensitive for primary syphilis
EIA/CIA 95-100% 95-100% Excellent sensitivity across all stages

Important Considerations

  • False-positive RPR results occur more commonly in:

    • Women (0.27% vs 0.20% in men)
    • Patients over 60 years (0.34% vs 0.25% in younger patients) 1
  • Discordant results (treponemal reactive/nontreponemal nonreactive) should be confirmed with additional treponemal testing to rule out false positives 1

  • Clinical context is crucial for interpretation, especially in:

    • Previously treated syphilis (treponemal tests typically remain positive for life)
    • Early primary syphilis (tests may be negative)
    • Neurosyphilis evaluation (requires CSF testing)

After Confirmation

Once syphilis is confirmed, additional steps include:

  1. Staging based on clinical presentation and history
  2. Treatment with appropriate penicillin regimen based on stage
  3. Follow-up testing with quantitative nontreponemal tests at 3,6,9, and 12 months to monitor treatment response 1
  4. Partner notification and treatment

Pitfalls to Avoid

  • Don't rely solely on nontreponemal tests for diagnosis as they lack specificity
  • Don't use treponemal tests to monitor treatment response as they typically remain positive for life
  • Don't confuse reinfection with treatment failure when titers increase after initial decline
  • Don't miss neurosyphilis evaluation in patients with late latent syphilis, CD4 count <350 cells/mm³ with high-titer VDRL (>1:32), or treatment failure 1

References

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Performance of Treponemal Tests for the Diagnosis of Syphilis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.